30 Day Trial

Xtant Losses Continue in 2Q19 on Lumbar Implant Recall

Share:

Xtant reports 2Q19 revenue of USD $15.3MM, -18.5% vs. 2Q18.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.